Forget Vodafone! I’d go for this serial dividend-raiser and its solid business instead

I’d avoid Vodafone plc (LON: VOD) and buy shares in this defensive, growing company to lock in its rising dividend.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Telecommunications giant Vodafone has been struggling to raise its dividend and the shares have been falling. I’d look elsewhere for a rising dividend backed by a decent business.

I wrote in January that Emis Group (LSE: EMIS) has been growing its revenue, normalised earnings, operating cash flow and the dividend for years. There’s a strong balance sheet with a pile of net cash and I reckon the company’s business has some decent defensive characteristics.

Good figures

Operations involve providing software and support services to GP practices, hospitals pharmacies, satellite healthcare centres and “across every major UK healthcare setting.”

And the market likes today’s full-year results report judging by this morning’s uplift in the share price of around 8% as I write.

The figures reveal overall revenue grew 6% during the year and recurring revenue lifted 5%. In terms of the adjusted numbers, net cash from operations moved 10% higher and earnings per share came in flat. The progress showed up on the balance sheet with the firm posting a 12% lift in net cash to £15.6m. This is a positive outcome extending the firm’s record. The directors expressed their approval, and confidence in the outlook, by pushing up the total dividend for the year by 10%.

Chief executive Andy Thorburn said in the report that revenue grew in all the firm’s key segments and much of it can be categorised as ‘recurring’, which I reckon adds to the defensive appeal of the business. The outcome was decent cash generation, which supports the progressive dividend policy and Thorburn thinks the firm is “well positioned” for future expansion.

Planning for growth

The company has been planning and investing for growth and, in 2018, “considerable management time” went into developing the strategy and attracting new talent to the business. The firm made 21 “key senior hires,” which sets it up well for 2019.

Back in January, with the share price around 897p, I said “I’d be happy to dip my toe in the water by buying a few of the company’s shares.” If I’d done so, today’s price close to 1,034p would be showing me a capital gain of just over 15%. However, I think there’s much more potential in Emis and I’d want to tuck some of the shares away for the long haul.

City analysts following the firm have pencilled in earnings increases of around 9% for this year and for 2020. The forward price-to-earnings ratio sits close to 19 two years out, and the predicted dividend yield is running a little under 3.2%. The valuation looks to be up with events, but I reckon the company is worth a premium because of the consistency of its results over several years. To me, Emis is worth keeping a close eye on with a view to buying some of the shares on dips and down-days with a view to holding onto them for the long haul.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kevin Godbold has no position in any share mentioned. The Motley Fool UK has recommended Emis Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Businessman use electronic pen writing rising colorful graph from 2023 to 2024 year of business planning and stock investment growth concept.
Growth Shares

The Scottish Mortgage share price is smashing the FTSE 100 again

Year to date, the Scottish Mortgage share price has risen far more than the Footsie has. Edward Sheldon expects this…

Read more »

Investing Articles

As H1 results lift the Land Securities share price, should I buy?

An improving full-year outlook could give the Land Securities share price a boost. But economic pressures on REITs are still…

Read more »

Young Caucasian man making doubtful face at camera
Investing Articles

How much are Rolls-Royce shares really worth as we approach 2025?

After starting the year at 300p, Rolls-Royce shares have climbed to 540p. But are they really worth that much? Edward…

Read more »

Investing Articles

Despite rocketing 33% this hidden FTSE 100 gem is still dirt cheap with a P/E under 5!

Harvey Jones has been tracking this under -the-radar FTSE 100 growth stock for some time. He thinks it looks a…

Read more »

Dividend Shares

How I could earn a juicy second income starting with just £250

Jon Smith explains how investing a regular amount each month in dividend stocks with above average yields can build a…

Read more »

Young female hand showing five fingers.
Investing Articles

If I’d put £10,000 into the FTSE 250 5 years ago, here’s how much I’d have now!

The FTSE 250 hasn’t done well over the past five years. But by being selective about which of its stocks…

Read more »

Senior woman wearing glasses using laptop at home
Investing Articles

With UK share prices dipping, I’m considering two opportunities in penny stocks

A market dip has presented opportunities in UK shares, particularly in cheap penny stocks. With bargain prices across the board,…

Read more »

Investing Articles

2 promising British value stocks I’d consider for a Stocks & Shares ISA next year

Despite the recent slowdown, the Footsie is still packed with exceptional stocks and shares. Here are two our writer would…

Read more »